HSD17B13 rs72613567 protects against liver diseases and histological progression of nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Wang, P; Wu, C-X; Li, Y; Shen, N

Wang, P; Wu, C-X; Li, Y; Shen, N.

Affiliation

Wang P; Institute and Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. shenna@tjh.tjmu.edu.cn.

Eur Rev Med Pharmacol Sci ; 24(17): 8997-9007, 2020 09.

Article in En | MEDLINE | ID: mdl-32964989

Subject(s)

17-Hydroxysteroid Dehydrogenases/metabolism; Liver Diseases/metabolism; Non-alcoholic Fatty Liver Disease/metabolism; 17-Hydroxysteroid Dehydrogenases/genetics; Disease Progression; Humans; Liver Diseases/pathology; Non-alcoholic Fatty Liver Disease/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease / 17-Hydroxysteroid Dehydrogenases / Liver Diseases Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google